Novacyt SA - Surrey-based biotechnology group focused on clinical diagnostics - Announces that the UK Department of Health & Social Care has issued a claim against it and its subsidiary Primerdesign Ltd. Claim of GBP134.6 million issued by the department is part of an ongoing contract dispute between the company and the department.
In 2020 and 2021, Novacyt provided Covid-19-testing kits to the department under a multi-million pound contract. A contract from September 2020 is in dispute.
Current stock price: 168.06 pence, down 14% on Tuesday
12-month change: down 67%
By Tom Budszus; tombudszus@alliancenews.com
Copyright 2022 Alliance News Limited. All Rights Reserved.